PMDA announcement: Second FY2025 survey results on safe use of drugs and regenerative medical products
2025年度（令和7年度）第2回医薬品・再生医療等製品の安全使用に関する調査結果を掲載しました
Published: 2026-05-08 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Low · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
On 2026-05-08, the Pharmaceuticals and Medical Devices Agency (PMDA) announced publication of results from the second FY2025 survey on the safe use of pharmaceuticals and regenerative medical products. The title does not provide the findings or identify any regulatory changes.
Business Impact
The results may be relevant to healthcare professionals using pharmaceuticals and regenerative medical products because the survey concerns their safe use; specific operational implications cannot be determined from the title.
Recommended Action
Reviewing the official PMDA publication may help clarify the survey findings, their scope, and any stated safety considerations.